Home  »  News   »  Here is why VBI Vaccines Inc. (VBIV) recent weekly...

Here is why VBI Vaccines Inc. (VBIV) recent weekly performance of -13.68% shouldn’t bother you at All

For the readers interested in the stock health of VBI Vaccines Inc. (VBIV). It is currently valued at $0.33. When the transactions were called off in the previous session, Stock hit the highs of $0.375, after setting-off with the price of $0.362. Company’s stock value dipped to $0.33 during the trading on the day. When the trading was stopped its value was $0.37.Recently in News on March 13, 2023, VBI Vaccines Reports Full Year 2022 Financial Results. Access to PreHevbrio [Hepatitis B Vaccine (Recombinant)] continues to broaden in the U.S. and beyond, with additional approvals received in 2022 in Europe and Canada. You can read further details here

VBI Vaccines Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.8600 on 03/29/22, with the lowest value was $0.3300 for the same time period, recorded on 03/15/23.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


VBI Vaccines Inc. (VBIV) full year performance was -73.86%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, VBI Vaccines Inc. shares are logging -82.15% during the 52-week period from high price, and -0.60% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.33 and $1.86.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1314354 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the VBI Vaccines Inc. (VBIV) recorded performance in the market was -15.11%, having the revenues showcasing -34.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 89.20M, as it employees total of 149 workers.

The Analysts eye on VBI Vaccines Inc. (VBIV)

During the last month, 0 analysts gave the VBI Vaccines Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.5373, with a change in the price was noted -0.31. In a similar fashion, VBI Vaccines Inc. posted a movement of -48.48% for the period of last 100 days, recording 918,671 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VBIV is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.58.

Technical rundown of VBI Vaccines Inc. (VBIV)

Raw Stochastic average of VBI Vaccines Inc. in the period of last 50 days is set at 0.54%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 0.83%. In the last 20 days, the company’s Stochastic %K was 7.28% and its Stochastic %D was recorded 6.91%.

Considering, the past performance of VBI Vaccines Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -15.11%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -59.62%, alongside a downfall of -73.86% for the period of the last 12 months. The shares increased approximately by -13.68% in the 7-day charts and went up by -45.04% in the period of the last 30 days. Common stock shares were lifted by -34.84% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts